Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
31.99
+0.20 (0.63%)
Apr 27, 2026, 11:43 AM EDT - Market open
Sensei Biotherapeutics Employees
As of December 31, 2024, Sensei Biotherapeutics had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 13 or -46.43% compared to the previous year.
Employees
15
Change (1Y)
-13
Growth (1Y)
-46.43%
Revenue / Employee
n/a
Profits / Employee
-$1,405,667
Market Cap
42.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | 32 | - | - | 30 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Werewolf Therapeutics | 39 |
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| Atara Biotherapeutics | 14 |
| Rallybio | 14 |
| Rein Therapeutics | 10 |
SNSE News
- 10 days ago - Sensei Biotherapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 18 days ago - Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 4 weeks ago - Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - Business Wire
- 5 weeks ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Sensei Biotherapeutics Transcript: M&A announcement - Transcripts
- 2 months ago - Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
- 3 months ago - Egle Therapeutics Appoints John Celebi as Chief Executive Officer - GlobeNewsWire
- 5 months ago - Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire